Short Term Efficacy of a Starting Dose of 12.5 mg of Prednisone in Polymyalgia Rheumatica Patients
Condition(s):Polymyalgia RheumaticaLast Updated:July 26, 2010Completed
Hide Studies Not Open or Pending
Condition(s):Polymyalgia RheumaticaLast Updated:July 26, 2010Completed
Condition(s):Polymyalgia RheumaticaLast Updated:May 24, 2023Recruiting
Condition(s):Polymyalgia RheumaticaLast Updated:June 3, 2019Unknown status
Condition(s):Polymyalgia RheumaticaLast Updated:May 24, 2023Recruiting
Condition(s):Polymyalgia RheumaticaLast Updated:August 1, 2023Completed
Condition(s):Horton’s DiseaseLast Updated:February 21, 2024Completed
Condition(s):Polymyalgia RheumaticaLast Updated:May 20, 2022Active, not recruiting
Condition(s):Polymyalgia Rheumatica (PMR)Last Updated:January 17, 2018Completed
Condition(s):Temporal ArteritisLast Updated:May 26, 2010Unknown status
Condition(s):Giant Cell ArteritisLast Updated:December 2, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.